Kinetic mapping of the antibody combining site by chemical relaxation spectrometry.

PubWeight™: 1.68‹?› | Rank: Top 3%

🔗 View Article (PMID 4826892)

Published in Biochemistry on May 07, 1974

Authors

D Haselkorn, S Friedman, D Givol, I Pecht

Articles citing this

Kinetic evidence for hapten-induced conformational transition in immunoglobin MOPC 460. Proc Natl Acad Sci U S A (1976) 1.32

The combining site of the dinitrophenyl-binding immunoglobulin A myeloma protein MOPC 315. Biochem J (1977) 1.17

Activation specificity of arsonate-reactive T cell clones. Structural requirements for hapten recognition and comparison with monoclonal antibodies. J Exp Med (1984) 1.14

Interactions of the lanthanide- and hapten-binding sites in the Fv fragment from the myeloma protein MOPC 315. Biochem J (1976) 1.09

Differences in electrostatic properties at antibody-antigen binding sites: implications for specificity and cross-reactivity. Biophys J (2002) 1.03

The gross architecture of an antibody-combining site as determined by spin-label mapping. Biochem J (1977) 0.92

Specificity of interactions of hapten side chains with the combining site of the myeloma protein MOPC 315. Biochem J (1977) 0.91

Hapten-linked conformational equilibria in immunolglobulins XRPC-24 and J-539 observed by chemical relaxation. Biophys J (1978) 0.88

Dimerization kinetics of the IgE-class antibodies by divalent haptens. I. The Fab-hapten interactions. Biophys J (1992) 0.86

The binding of 2,4,6-trinitrophenyl derivatives to the mouse myeloma immunoglobulin A protein MOPC 315. Biochem J (1978) 0.85

A comparison of the isoelectrofocusing porperties of antibodies to DNP, DNP-glycylglycylglycine and DNP-p-aminobenzoylglutamate. Immunology (1975) 0.84

Resonance Raman-spectroscopic studies of the hapten features involved in the binding of 2,4-dinitrophenyl haptens by the mouse myeloma proteins MOPC 315 and MOPC 460. Biochem J (1978) 0.84

The role of nitro groups in the binding of nitroaromatics to protein MOPC 315. Biochem J (1978) 0.80

N-bromosuccinimide oxidation of anti-DNP and anti-DNP-p-aminobenzoylglutamate antibodies in the presence and absence of protecting hapten. Immunology (1975) 0.79

Structure-function relations in phosphorylcholine-binding mouse myeloma proteins. Proc Natl Acad Sci U S A (1977) 0.75

The variability of nitro group--protein interaction in the 2,4-dinitrophenyl-binding antibodies M315, M460 and X25 investigated by resonance Raman spectroscopy. Biochem J (1981) 0.75

Articles by these authors

Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature (1985) 6.86

Sequence of chicken ovalbumin mRNA. Nature (1978) 6.73

Ribosomal RNA sequence suggests microsporidia are extremely ancient eukaryotes. Nature (1987) 4.40

Nucleotide sequence of the rat skeletal muscle actin gene. Nature (1982) 3.81

The isolation of antibiotic-resistant salmonella from retail ground meats. N Engl J Med (2001) 3.55

Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res (1994) 3.54

The retained surgical sponge. Ann Surg (1996) 3.46

DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene (2001) 3.28

Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. EMBO J (1985) 3.18

Subnanosecond motions of tryptophan residues in proteins. Proc Natl Acad Sci U S A (1979) 3.06

A single gene and a pseudogene for the cellular tumour antigen p53. Nature (1984) 2.98

Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol (1993) 2.96

Analysis of the gene coding for the murine cellular tumour antigen p53. EMBO J (1984) 2.94

Nucleotide sequence and expression of the gene encoding the EcoRII modification enzyme. Nucleic Acids Res (1987) 2.68

Skeletal muscle actin mRNA. Characterization of the 3' untranslated region. Nucleic Acids Res (1981) 2.67

Localization of gene for human p53 tumour antigen to band 17p13. Nature (1986) 2.56

The impact of physician bonuses, enhanced fees, and feedback on childhood immunization coverage rates. Am J Public Health (1999) 2.52

Diversity of germ-line immunoglobulin VH genes. Nature (1981) 2.47

All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor. J Biol Chem (1989) 2.46

Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element. Nature (1982) 2.45

Hospitalization in the Program of All-Inclusive Care for the Elderly (PACE): rates, concomitants, and predictors. J Am Geriatr Soc (2000) 2.38

Capsule endoscopy structured terminology (CEST): proposal of a standardized and structured terminology for reporting capsule endoscopy procedures. Endoscopy (2005) 2.34

Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc Natl Acad Sci U S A (1996) 2.30

Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology (1999) 2.25

Activation of the c-mos oncogene in a mouse plasmacytoma by insertion of an endogenous intracisternal A-particle genome. Proc Natl Acad Sci U S A (1983) 2.23

Purification and properties of the Escherichia coli deoxyribonucleic acid-unwinding protein. Effects on deoxyribonucleic acid synthesis in vitro. J Biol Chem (1974) 2.22

Identification and expression of cephamycinase bla(CMY) genes in Escherichia coli and Salmonella isolates from food animals and ground meat. Antimicrob Agents Chemother (2001) 2.22

Simple DNA sequences in homologous flanking regions near immunoglobulin VH genes: a role in gene interaction? Nucleic Acids Res (1982) 2.19

The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci U S A (1986) 2.18

Organization and evolution of immunoglobulin VH gene subgroups. Proc Natl Acad Sci U S A (1982) 2.18

The 5' region of the p53 gene: evolutionary conservation and evidence for a negative regulatory element. EMBO J (1985) 2.17

Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development (1991) 2.16

Markers for primary care: missed opportunities to immunize and screen for lead and tuberculosis by private physicians serving large numbers of inner-city Medicaid-eligible children. Pediatrics (1996) 2.14

3,4-dihydroxyphenylethylamine beta-hydroxylase. Physical properties, copper content, and role of copper in the catalytic acttivity. J Biol Chem (1965) 2.13

3-(3-amino-3-carboxy-n-propyl)uridine. The structure of the nucleoside in Escherichia coli transfer ribonucleic acid that reacts with phenoxyacetoxysuccinimide. Biochemistry (1974) 2.06

Characterization of Salmonella enterica serotype newport isolated from humans and food animals. J Clin Microbiol (2003) 2.02

Congenital left aortic sinus-left ventricle fistula and review of aortocardiac fistulas. Ann Thorac Surg (1977) 2.01

Developmental expression of c-kit, a proto-oncogene encoded by the W locus. Development (1990) 1.99

Homology between an endogenous viral LTR and sequences inserted in an activated cellular oncogene. Nature (1983) 1.98

Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). Proc Natl Acad Sci U S A (1989) 1.97

A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. EMBO J (1992) 1.93

General method for the detection of cells producing antibodies against haptens and proteins. Nature (1970) 1.92

Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules. EMBO J (1989) 1.90

The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc Natl Acad Sci U S A (1989) 1.86

Localization of antibody-combining sites within the variable portions of heavy and light chains. Proc Natl Acad Sci U S A (1972) 1.84

Identification and characterization of integron-mediated antibiotic resistance among Shiga toxin-producing Escherichia coli isolates. Appl Environ Microbiol (2001) 1.82

Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Aliment Pharmacol Ther (2005) 1.79

Chicken epidermal growth factor (EGF) receptor: cDNA cloning, expression in mouse cells, and differential binding of EGF and transforming growth factor alpha. Mol Cell Biol (1988) 1.77

Antigen-induced conformational changes in antibodies and their Fab fragments studied by circular polarization of fluorescence. Proc Natl Acad Sci U S A (1975) 1.76

A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Proc Natl Acad Sci U S A (1999) 1.75

Evolutionary aspects of immunoglobulin heavy chain variable region (VH) gene subgroups. Proc Natl Acad Sci U S A (1983) 1.72

A general method for the specific isolation of peptides containing modified residues, using insoluble antibody columns. Biochemistry (1971) 1.70

Common peptides from the N-terminal half of heavy chain of immunoglobulin G from normal rabbit serum and a specific antibody. Biochem J (1968) 1.69

A test for the practical evaluation of male fertility by acridine orange (AO) fluorescence. Fertil Steril (1984) 1.68

An active antibody fragment (Fv) composed of the variable portions of heavy and light chains. Biochemistry (1973) 1.68

Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling. Mol Cell Biol (1988) 1.67

Rearrangement of the oncogene c-mos in mouse myeloma NSI and hybridomas. Nature (1984) 1.66

Effect of electric fields on light-scattering and fluorescence of chromaffin granules. J Membr Biol (1975) 1.64

The inhibition of DNA(cytosine-5)methylases by 5-azacytidine. The effect of azacytosine-containing DNA. Mol Pharmacol (1981) 1.62

Cloning and expression of a widely expressed receptor tyrosine phosphatase. Proc Natl Acad Sci U S A (1990) 1.61

Nucleotide sequence analysis identifies the human c-sis proto-oncogene as a structural gene for platelet-derived growth factor. Cell (1984) 1.61

Gestational diabetes mellitus. A survey of perinatal complications in the 1980s. Diabetes (1991) 1.61

Transfer of the methyl group from N5-methyltetrahydrofolates to homocysteine in Escherichia coli. Biochem J (1964) 1.59

The nucleotide sequence of rat alpha-tubulin: 3'-end characteristics, and evolutionary conservation. Nucleic Acids Res (1981) 1.58

"Retroposon" insertion into the cellular oncogene c-myc in canine transmissible venereal tumor. Proc Natl Acad Sci U S A (1985) 1.56

Differences in the locational attainment of immigrant and native-born households with children in New York City. Demography (2001) 1.56

Analysis of recombinant DNA clones specific for the murine p53 cellular tumor antigen. EMBO J (1983) 1.55

Model-building studies of antigen-binding sites: the hapten-binding site of mopc-315. Cold Spring Harb Symp Quant Biol (1977) 1.54

Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health (1993) 1.53

Antimicrobial resistance and genetic relatedness among Salmonella from retail foods of animal origin: NARMS retail meat surveillance. Foodborne Pathog Dis (2006) 1.52

Binding of the EcoRII methylase to azacytosine-containing DNA. Nucleic Acids Res (1986) 1.51

Possible orientational constraints determine secretory signals induced by aggregation of IgE receptors on mast cells. EMBO J (1988) 1.50

Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells. Leukemia (2006) 1.50

Correlated expression of VH framework and VH idiotypic determinants on T helper cells and on functionally undefined T cells binding group A streptococcal carbohydrate. Eur J Immunol (1980) 1.50

HIV transmission through donor artificial insemination. JAMA (1995) 1.49

Purification and properties of an enzyme from beef liver which catalyzes sulfhydryl-disulfide interchange in proteins. J Biol Chem (1966) 1.48

Effects of chloroquine on the feeding mechanism of the intraerythrocytic human malarial parasite Plasmodium falciparum. J Protozool (1984) 1.46

Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues. Cancer Res (1988) 1.45

Fluorescence resonance energy transfer on single living cells. Application to binding of monovalent haptens to cell-bound immunoglobulin E. Biophys J (1991) 1.44

Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc Natl Acad Sci U S A (1992) 1.44

A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy (2005) 1.43

Isolation and characterization of mitochondrial DNA from Drosophila melanogaster. J Cell Biol (1973) 1.43

Surgical results of intrathoracic gastric volvulus complicating hiatal hernia. Br J Surg (1990) 1.43

Improved specificity of myoglobin plus carbonic anhydrase assay versus that of creatine kinase-MB for early diagnosis of acute myocardial infarction. Ann Emerg Med (1996) 1.42

Protein kinase C regulation of the receptor-coupled calcium signal in histamine-secreting rat basophilic leukaemia cells. Nature (1985) 1.42

Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells. Oncogene (2010) 1.42

Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer (1989) 1.41

The irreversible binding of azacytosine-containing DNA fragments to bacterial DNA(cytosine-5)methyltransferases. J Biol Chem (1985) 1.40

Promoter and enhancer elements in the rearranged alpha chain gene of the human T cell receptor. EMBO J (1987) 1.40

Periapical health and treatment quality assessment of root-filled teeth in two Canadian populations. Int Endod J (2003) 1.40

Genetic testing for cancer predisposition--an ongoing debate. Lancet Oncol (2000) 1.39

A specific combination of substrates is involved in signal transduction by the kit-encoded receptor. EMBO J (1991) 1.39

Association between milk production, somatic cell count and bacterial dermatoses in three dairy cattle herds. Aust Vet J (2000) 1.39

Effects of sodium lactate infusion on cisternal lactate and carbon dioxide levels in nonhuman primates. Am J Psychiatry (1992) 1.38

A successful technique for the treatment of diabetic neurotrophic ulcers. J Am Podiatr Med Assoc (1992) 1.38

Imipramine and alprazolam treatment of lactate-induced acute endogenous distress in nonhuman primates. Am J Psychiatry (1989) 1.38

DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1. Oncogene (2001) 1.37

Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity. Proc Natl Acad Sci U S A (1994) 1.37